Can Oral Rehydration Solution (ORS) be given to patients with Chronic Kidney Disease (CKD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

ORS can be given to CKD patients, but with caution and under medical supervision, considering their individualized needs and electrolyte imbalances. For CKD patients, standard ORS formulations may need modification due to their high sodium and potassium content, which could worsen fluid retention and electrolyte imbalances, as there is no proven benefit in using disease-specific enteral formulas in critically ill patients 1. When necessary, a reduced-sodium ORS or a custom formulation may be prescribed by a nephrologist, taking into account the calorie and protein ratio to provide the most accurate dosing in clinical practice 1. The choice of the most appropriate formula should be made based on the patient's individual needs, and in selected patients with electrolyte and fluid imbalances, concentrated “renal” formulas with lower electrolyte content may be preferred over standard formulas 1. Some key considerations for ORS administration in CKD patients include:

  • Fluid intake should align with the patient's prescribed fluid restriction, typically ranging from 1-2 liters daily depending on CKD stage and residual kidney function
  • Regular electrolyte checks, especially potassium and sodium levels, are crucial to prevent complications like hyperkalemia, hyponatremia, or fluid overload
  • The patient's individualized needs and electrolyte imbalances should guide the choice of ORS formulation and administration schedule
  • Damaged kidneys have reduced ability to excrete excess electrolytes and maintain fluid balance, so standard hydration approaches must be modified to prevent complications like pulmonary edema or heart failure exacerbation.

From the Research

Oral Rehydration Solutions (ORS) in CKD Patients

  • There is no direct evidence in the provided studies that specifically addresses the use of ORS in CKD patients 2, 3, 4, 5, 6.
  • However, the studies discuss fluid management and hydration in CKD patients, which may be relevant to the use of ORS.
  • A study on oral hydration compared to intravenous hydration in the prevention of post-contrast acute kidney injury in patients with chronic kidney disease stage IIIb found that oral hydration was non-inferior to intravenous hydration 5.
  • This suggests that oral hydration, which may include ORS, can be effective in managing fluid balance in CKD patients.
  • However, it is essential to note that CKD patients require careful management of fluid and electrolyte balance, and the use of ORS should be approached with caution and under medical supervision.
  • The provided studies do not specifically address the safety and efficacy of ORS in CKD patients, and more research is needed to determine its suitability for this population.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.